Stock Market Focus: Key Updates on TCS, HUL, and Glenmark Pharma

On July 11, 2025, notable movements in the Indian stock market are anticipated, particularly for major companies such as Tata Consultancy Services (TCS), Hindustan Unilever (HUL), and Glenmark Pharmaceuticals. TCS, the largest IT services firm in India, reported a significant net profit of ₹12,760 crore for the first quarter of FY26, reflecting a 6% increase from the ₹12,040 crore profit recorded in the same quarter of the previous year. This performance was above analysts' expectations, with HSBC predicting a net profit of ₹11,925 crore. The company also reported an operating margin of 24.5%, which represents a sequential improvement of 30 basis points. According to Jitendra Sinha, an analyst at HSBC, "TCS’s solid quarterly results indicate strong demand for IT services, which could bolster investor confidence in the sector moving forward."

In addition to TCS, HUL, a leader in the fast-moving consumer goods (FMCG) sector, will be in the spotlight following the announcement of Priya Nair as its first female CEO and Managing Director, effective August 1, 2025. Nair, currently the President of Beauty & Wellbeing at Unilever, is set to replace Rohit Jawa, who is stepping down to pursue other opportunities. This historic appointment is seen as a significant step towards gender diversity in corporate leadership, according to Dr. Anjali Rao, a gender studies expert at the University of Delhi. "Nair’s elevation marks a pivotal moment in the Indian corporate landscape, potentially inspiring more women to take on leadership roles in traditionally male-dominated sectors," Dr. Rao stated.

The stock market is also keenly observing other companies. For instance, Glenmark Pharmaceuticals recently established a landmark partnership with AbbVie for the development of ISB 2001, a trispecific antibody aimed at treating certain cancers. This collaboration is expected to enhance Glenmark's position in the biopharmaceutical arena, emphasizing its commitment to innovation in drug development. Dr. Vikram Shah, CEO of Glenmark, remarked, "This partnership not only strengthens our pipeline but also aligns with our strategy to expand our footprint in oncology globally."

The Indian Renewable Energy Development Agency (IREDA) is under scrutiny as it reported a 36% decline in net profit to ₹247 crore for the June quarter, compared to ₹384 crore in the same quarter last year, largely due to rising expenses. Despite this setback, revenue from operations improved significantly, indicating resilience in the renewable energy sector.

Furthermore, Tata Elxsi's recent quarterly results showed a decline in net profit to ₹144.4 crore, a decrease of 21.6% year-on-year, raising concerns among analysts about its profitability and operational efficiency.

As the domestic market anticipates a lower opening with the NIFTY50 index expected to dip by 135 points, investors remain cautious but hopeful for recovery in the latter half of the fiscal year. The upcoming announcements from 14 companies, including Avenue Supermarts and Elecon Engineering, are also expected to shape market sentiments moving forward.

In summary, while TCS and HUL take center stage with their transformative changes and financial results, other companies in the IT and FMCG sectors are also poised to influence market movements significantly. Analysts underscore the importance of these developments, suggesting that they could have lasting implications on investor strategies and market dynamics in the coming months.